Epigenomics AG and NEXT-pharmaceutical sign world-wide agreement over order production of intestine cancer blood test
The molecular diagnostics enterprise Epigenomics AG and NEXT-pharmaceutical Technologies, the prominent European offerers for production development, order production, cooling chain and logistics outsourcing for the pharmaceutical and biotechnological industry, communicated today that the enterprise…